J0850: Injection, cytomegalovirus immune globulin intravenous (human), per vial

Category

J. Drugs administered other than oral method

Medicare allowed amount

$1,857.125 per per vialSource: October 2026 Medicare Part B Payment Limit File, October 1, 2026 through December 31, 2026.

CMS HCPCS quarterly update

These sit next to J0850 in the CMS Level II file. All J codes

• J0802Injection, corticotropin (ani), up to 40 units
• J0833Injection, cosyntropin, not otherwise specified, 0.25 mg
• J0834Injection, cosyntropin, 0.25 mg
• J0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
• J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg
• J0870Injection, imetelstat, 1 mg
• J0871Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
• J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
• J0873Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
• J0874Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg

An NDC (National Drug Code) is the FDA number for one drug package. CMS's ASP crosswalk (ASP is average sales price, the basis for Medicare Part B drug payment) links each NDC to the HCPCS code the drug is billed under, with the billable units CMS lists for it.

Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.